Completed
The Assessment of Copper Parameters in Wilson Disease Participants on Standard of Care Treatment
NCT02763215
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Brain Diseases, Metabolic, +16 more
- Locations
-
- Clinical Trial Site New Haven, Connecticut, United States
- Clinical Trial Site Chicago, Illinois, United States
- Clinical Trial Site Ann Arbor, Michigan, United States
- Clinical Trial Site Nashville, Tennessee, United States